DprE1-IN-25

CAS No. 1615713-87-5

DprE1-IN-25 ( MDK3875; MDK-3875; MDK 3875; DprE1-IN-2; DprE1IN2 )

Catalog No. M12351 CAS No. 1615713-87-5

A potent, noncovalent DprE1 inhibitor with IC50 of 43 nM, shows activity against Mycobacterium tuberculosis (Mtb) in vitro with MIC of 0.39 uM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 53 In Stock
5MG 87 In Stock
10MG 132 In Stock
25MG 259 In Stock
50MG 384 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DprE1-IN-25
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, noncovalent DprE1 inhibitor with IC50 of 43 nM, shows activity against Mycobacterium tuberculosis (Mtb) in vitro with MIC of 0.39 uM.
  • Description
    A potent, noncovalent DprE1 inhibitor with IC50 of 43 nM, shows activity against Mycobacterium tuberculosis (Mtb) in vitro with MIC of 0.39 uM.
  • Synonyms
    MDK3875; MDK-3875; MDK 3875; DprE1-IN-2; DprE1IN2
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    DprE
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    1615713-87-5
  • Formula Weight
    368.43
  • Molecular Formula
    C19H24N6O2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: ≥ 33 mg/mL
  • SMILES
    O=C(C1=CN(CC2=NC=NC(N(C)C)=C2C)C3=CC(C)=CN=C31)NCCO
  • Chemical Name
    1H-Pyrrolo[3,2-b]pyridine-3-carboxamide, 1-[[6-(dimethylamino)-5-methyl-4-pyrimidinyl]methyl]-N-(2-hydroxyethyl)-6-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shirude PS, et al. J Med Chem. 2014 Jul 10;57(13):5728-37.
molnova catalog
related products
  • Walrycin-B

    A novel baterial WalR response regulator; simultaneously affects the expression of WalR regulon genes.

  • Tizoxanide

    Tizoxanide is the main metabolite of nitazoxanide, which is a synthetic nitrothiazolyl-salicylamide derivative and an antiprotozoal agent.

  • Taniborbactam

    Taniborbactam is a novel beta-lactamase inhibitor for the treatment of bacterial infections.